Last Posted: Aug 02, 2018
- KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010-2013.
Charlton Mary E et al. Journal of the National Comprehensive Cancer Network : JNCCN 2017 Dec 15(12) 1484-1493 - [Feasibility of amplicon-based targeted next-generation sequencing of colorectal cancer in endoscopic biopsies].
Wang Y J et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 Jul 47(7) 499-504 - Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.
Peluso Gaia et al. BioMed research international 2017 20172605628 - Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.
Morgen E K et al. The pharmacogenomics journal 2017 Dec 17(6) 535-542 - Molecular analysis of single circulating tumour cells following long-term storage of clinical samples.
Mesquita Barbara et al. Molecular oncology 2017 Dec 11(12) 1687-1697 - No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
Engel Christoph et al. Gastroenterology 2018 Jul - Pharmacogenetics of anticancer drug sensitivity and toxicity in colorectal cancer.
Moradi-Marjaneh Reyhaneh et al. Current pharmaceutical design 2018 Jul - Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines.
Arakawa Keiichi et al. Anticancer research 2018 Aug 38(8) 4871-4876 - Routine molecular analysis for Lynch syndrome among adenomas or colorectal cancer within a national screening program.
Goverde A et al. Gastroenterology 2018 Jul - Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study.
Udar Nitin et al. Journal of cancer research and clinical oncology 2018 Jul
.png)
No hay comentarios:
Publicar un comentario